Overview

Hepatic Metabolic Changes in Response to Glucagon Infusion

Status:
Completed
Trial end date:
2019-06-12
Target enrollment:
Participant gender:
Summary
The objective of the study is to investigate how exogenously administered glucagon affects hepatic lipid, glucose and protein metabolism as well as appetite, food intake and resting energy expenditure.
Phase:
N/A
Details
Lead Sponsor:
Steno Diabetes Center
Steno Diabetes Center Copenhagen
Collaborator:
University of Copenhagen
Treatments:
Glucagon
Glucagon-Like Peptide 1